Stocktoria

Translational Development Acquisition Corp. TDAC

Nasdaq · stock · Blank Checks · IPO 2024-12-23

Translational Development Acquisition Corp. statistics & valuation

Market cap$284.0M
P / E44.6×
Return on capital-0.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202320242025
Operating margin (%)
202320242025
Return on equity (%)
202320242025
Shares outstanding
0 0 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-24025.20% 0.00% 3.50% 202320242025
Free cash flow margin (%)
202320242025
Debt / equity (×)
202320242025
EPS ($)
202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Return on assets3.5%-0.0%-24025.2%
Return on equity-97.3%1.3%95.6%
Current ratio0.073.090.00

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.